CONCEPTUS INC
10-Q, 1997-08-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: WIREKRAFT INDUSTRIES INC, S-1, 1997-08-14
Next: NORTHSTAR HEALTH SERVICES INC, 10-Q, 1997-08-14



<PAGE>

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                                   UNITED STATES
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549
                                ___________________
                                          
                                     FORM 10-Q
                                          
[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

                     FOR THE FISCAL QUARTER ENDED JUNE 30, 1997

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

                 For the Transition period from _____ to _________.
                                          
                          Commission file number:  0-27596
                                                   -------


                                  CONCEPTUS, INC.
               (Exact name of Registrant as specified in its charter)
                                          
                                          
                  DELAWARE                                       94-3170244
      (State or other jurisdiction of                        (I.R.S. Employer 
      incorporation or organization)                         Identification No.)
                                          
                                          
                                 1021 HOWARD AVENUE
                               SAN CARLOS, CA  94070
                      (Address of principal executive offices)

        Registrant's telephone number, including area code:  (415) 802-7240
                                          
                                ___________________
                                          
     Indicate by check mark whether the registrant (1) has filed all reports 
     required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
     of 1934 during the preceding 12 months (or for such shorter period that the
     registrant was required to file such reports), and (2) has been subject to 
     such filing requirements for at least the past 90 days.

     Yes  X                                                              No   
         ---                                                               ---

     As of June 30, 1997,  9,440,949 shares of the Registrant's Common Stock 
     were outstanding.

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
                                   CONCEPTUS, INC.
                                          
                   FORM 10-Q For the Quarter Ended June 30, 1997
                                          
                                       INDEX




                                                                            Page

          Facing sheet                                                        1

          Index                                                               2

Part I.   Financial Information

Item 1.   a)  Consolidated balance sheets at June 30, 1997 and December 31,
              1996                                                            3

          c)  Consolidated statements of operations for the three and six
              month periods ended June 30, 1997 and June 30, 1996             4

          c)  Consolidated statements of cash flows for the three and six
              month periods ended June 30, 1997 and June 30, 1996             5

          d)  Notes to consolidated financial statements                      6

Item 2.   Management's Discussion and Analysis of Financial Condition and
          Results of Operations                                               7

Item 3.   Quantitative and Qualitative Disclosures About Market Risk         10

Part II.  Other Information                                                11-12

          Signature                                                          13

          Index to Exhibits                                                  14

                                       2
<PAGE>


                         PART I:  FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

                                CONCEPTUS, INC.
                        (A DEVELOPMENT STAGE COMPANY)

                         CONSOLIDATED BALANCE SHEETS
             (IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)

<TABLE>
<CAPTION>

                                                                   June 30, 1997     December 31, 1996
                                                                   -------------    -------------------
                                                                    (Unaudited)
<S>                                                               <C>              <C>
ASSETS
  Current assets:
    Cash and cash equivalents                                       $  13,594            $  16,939 
    Short-term investments                                             11,096               18,286 
    Accounts receivable, net                                              361                  105 
    Inventories                                                           151                  182 
    Other current assets                                                  367                  234 
                                                                    ---------            ---------

  Total current assets                                                 25,569               35,746 

  Property and equipment, net                                           1,036                  543 

  Long-term investments                                                 7,884                3,796 

  Other assets                                                            904                    8 
                                                                    ---------            ---------

                                                                    $  35,393            $  40,093 
                                                                    ---------            ---------
                                                                    ---------            ---------

LIABILITIES AND STOCKHOLDERS' EQUITY
  Current liabilities:
    Accounts payable                                                $     910            $     588 
    Accrued compensation                                                  412                  455 
    Accrued acquisition costs                                               -                1,000 
    Other accrued liabilities                                             288                  302 
    Current portion of debt and capital lease obligations                  71                  119 
                                                                    ---------            ---------

  Total current liabilities                                             1,681                2,464 

  Long-term portion of debt and capital lease obligations                   7                   34 

  Commitments

  Stockholders' equity:
    Common stock, $0.003 par value, 30,000,000 shares authorized,      63,452               61,876 
       9,440,949 and 9,206,795 shares issued and outstanding at 
        June 30, 1997 and December 31, 1996, respectively
    Stockholder notes receivable                                          (49)                 (49)
    Deferred compensation                                                (451)                (559)
    Deficit accumulated during the development stage                  (29,247)             (23,673)
                                                                    ---------            ---------

  Total stockholders' equity                                           33,705               37,595 
                                                                    ---------            ---------

                                                                    $  35,393            $  40,093 
                                                                    ---------            ---------
                                                                    ---------            ---------
</TABLE>

                 See notes to consolidated financial statements.

                                       -3-
<PAGE>


                                 CONCEPTUS, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)
                     (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

<TABLE>
<CAPTION>

                                                         THREE MONTHS ENDED              SIX MONTHS ENDED 
                                                               JUNE 30,                       JUNE 30, 
                                                       ----------------------          ---------------------
                                                         1997           1996             1997          1996
                                                       -------        -------          -------       -------
<S>                                                  <C>            <C>              <C>           <C>
Net sales                                              $   424        $   105          $   701       $   187
Cost of sales                                              752            235            1,194           394
                                                       -------        -------          -------       -------

Gross profit                                              (328)          (130)            (493)         (207)

Operating expenses:
  Research and development                               1,411            915            2,969         1,703
  Selling, general and administrative                    1,483          1,200            3,048         2,192
                                                       -------        -------          -------       -------

Total operating expenses                                 2,894          2,115            6,017         3,895
                                                       -------        -------          -------       -------

Operating loss                                          (3,222)        (2,245)          (6,510)       (4,102)


Interest and investment income, net                        444            616              936         1,008
                                                       -------        -------          -------       -------

Net loss                                               $(2,778)       $(1,629)         $(5,574)      $(3,094)
                                                       -------        -------          -------       -------
                                                       -------        -------          -------       -------

Net loss per share                                     $ (0.30)       $ (0.18)         $ (0.60)      $ (0.41)
                                                       -------        -------          -------       -------
                                                       -------        -------          -------       -------

Shares used in computing net loss per share              9,348          9,127            9,287         7,629
                                                       -------        -------          -------       -------
                                                       -------        -------          -------       -------

</TABLE>

                 See notes to consolidated financial statements.

                                       -4-
<PAGE>

                                CONCEPTUS, INC.
                         (A DEVELOPMENT STAGE COMPANY)
                                                              
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (UNAUDITED)
                INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
                                (IN THOUSANDS)

<TABLE>
<CAPTION>

                                                                   THREE MONTHS ENDED              SIX MONTHS ENDED
                                                                        JUNE 30,                        JUNE 30,
                                                              ---------------------------     --------------------------
                                                                  1997            1996            1997           1996
                                                              -----------      ----------     ------------    ----------
<S>                                                          <C>            <C>             <C>            <C>
CASH FLOWS USED IN OPERATING ACTIVITIES                       
Net loss                                                      $  (2,778)     $  (1,629)       $  (5,574)     $  (3,094)

Adjustments to reconcile net loss to net cash                 
  from operating activities:
    Depreciation and amortization                                   128             76              218            139 
    Amortization of deferred compensation                           239             54              403            111 
    Changes in operating assets and liabilities:
       Accounts receivable                                         (186)           (18)            (256)           (56)
       Inventory                                                    225            (87)              31            (41)
       Other current assets                                         639             58             (133)           252 
       Accounts payable                                             103            (69)             322           (228)
       Accrued compensation                                         (55)           (24)             (43)           (12)
       Other accrued liabilities                                   (176)            75              123            314 
                                                              ---------      ---------        ---------      --------- 
  
Net cash used in operating activities                            (1,861)        (1,564)          (4,909)        (2,615)
                                                              ---------      ---------        ---------      --------- 

CASH FLOWS FROM/(USED IN) INVESTING ACTIVITIES                
Purchase of investments                                          (8,963)       (22,344)         (22,954)       (23,297)
Maturities of investments                                        11,873            184           26,056          2,090 
Capital expenditures                                               (558)          (113)            (711)          (188)
Change in other assets                                             (890)             1             (890)             3 
                                                              ---------      ---------        ---------      --------- 
  
Net cash from/(used in) investing activities                      1,462        (22,272)           1,501        (21,392)
                                                              ---------      ---------        ---------      --------- 
CASH FLOWS FROM/(USED IN) FINANCING ACTIVITIES                          
Proceeds from issuance of common stock                               76             45              138         44,073 
Principal payments on debt and capital obligations                  (32)           (41)             (75)           (80)
                                                              ---------      ---------        ---------      --------- 

Net cash from/(used in) financing activities                         44              4               63         43,993 
                                                              ---------      ---------        ---------      --------- 

Net change in cash and cash equivalents                            (355)       (23,832)          (3,345)        19,986 
Cash and cash equivalents at beginning of period                 13,949         46,666           16,939          2,848 
                                                              ---------      ---------        ---------      ---------
Cash and cash equivalents at end of period                    $  13,594      $  22,834        $  13,594      $  22,834 
                                                              ---------      ---------        ---------      ---------
                                                              ---------      ---------        ---------      ---------

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION              
Cash paid for interest                                        $       3      $       6        $       7      $      14 
                                                              ---------      ---------        ---------      ---------
                                                              ---------      ---------        ---------      ---------

SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING INFORMATION     
Conversion of preferred stock to common stock                 $   -          $   -            $   -          $  16,624 
                                                              ---------      ---------        ---------      ---------
                                                              ---------      ---------        ---------      ---------
Issuance of common stock to Microgyn shareholders             $   1,000      $   -            $   1,000      $   -    
                                                              ---------      ---------        ---------      ---------
                                                              ---------      ---------        ---------      ---------

</TABLE>

                 See notes to consolidated financial statements.

                                       -5-
<PAGE>


                    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
                                     UNAUDITED

NOTE 1.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

METHOD OF PREPARATION

     The accompanying consolidated balance sheet as of June 30, 1997 and the 
consolidated statements of operations and cash flows for the three and six 
month periods ended June 30, 1997 and 1996 have been prepared by Conceptus, 
Inc. ("Conceptus" or the "Company"), without audit.  In the opinion of 
management, all adjustments necessary to present fairly the financial 
position, results of operations, and cash flows at June 30, 1997, and for all 
periods presented, have been made. 

     Although the Company believes that the disclosures in these financial 
statements are adequate to make the information presented not misleading, 
certain information and footnote disclosures required by Generally Accepted 
Accounting Principles for complete financial statements have been omitted 
pursuant to the rules and regulations of the Securities and Exchange 
Commission ("SEC"). This financial data should be reviewed in conjunction 
with the audited financial statements and notes thereto included in the 
Company's Form 10-K for the year ended December 31, 1996. The results of 
operations for the three and six months ended June 30, 1997 may not 
necessarily be indicative of the operating results for the full 1997 fiscal 
year. 

COMPUTATION OF NET LOSS PER SHARE

     In February 1997, the Financial Accounting Standards Board issued 
Statement No. 128, Earnings per Share, which is required to be adopted on 
December 31, 1997.  At that time, the Company will be required to change the 
method currently used to compute earnings per share and to restate all prior 
periods.  Under the new requirements for calculating primary earnings per 
share, the dilutive effect of stock options will be excluded.  The impact of 
Statement 128 is expected to result in no change to the Company's net loss 
per share for the three and six month periods ended June 30, 1997 and 1996, 
because antidilutive stock options have been excluded from the current 
computation.  The impact of Statement 128 on the calculation of fully diluted 
earnings per share for these periods is not expected to be material.

 RECLASSIFICATION

     Certain prior year amounts have been reclassified to conform with 
current year presentation.

                                       6
<PAGE>

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS

     The following discussion should be read in conjunction with the 
unaudited financial statements and notes thereto included in Part I-Item 1 of 
this Quarterly Report.  In addition, except for the historical statements 
contained therein, the following discussion contains forward-looking 
statements within the meaning of Section 21E of the Securities Exchange Act 
of 1934, as amended.  The Company wishes to alert readers that the factors 
set forth in the Company's Annual Report on Form 10-K for the year ended 
December 31, 1996 and in the Company's prospectus dated February 1, 1996 
under the heading "Risk Factors", as well as other factors, including those 
set forth in the following discussion could in the future affect, and in the 
past have affected, the Company's actual results and could cause the 
Company's results for future periods to differ materially from those 
expressed in any forward-looking statements made by or on behalf of the 
Company.

OVERVIEW

     Since its inception on September 18, 1992, Conceptus has been primarily 
engaged in  the design, development and marketing of innovative medical 
devices that provide minimally invasive devices for reproductive 
applications.  The Company has a limited history of operations and has 
experienced significant operating losses since inception.  Operating losses 
are expected to continue for at least the next several years as the Company 
continues to expend substantial resources to fund clinical trials in support 
of regulatory and reimbursement approvals, conduct research and development, 
and expand marketing and sales activities.  

     The Company's primary commercial products, the T-TAC (Transcervical 
Tubal Access Catheter) and STARRT (Selective Tubal Assessment to Refine 
Reproductive Therapy) Falloposcopy systems have generated limited sales to 
date.  The Company currently sells its products to international markets 
through a limited number of distributors who resell to physicians and 
hospitals.  Domestically, the Company sells its products through a small 
direct sales force and a distributor. In 1996, the Company made adjustments 
to the profile of its distributors, resulting in replacement and addition of 
new distributors in international markets. Sales to distributors are made on 
open credit terms and may include purchase discounts.  Sales in 1997 and 1996 
consisted primarily of commercial shipments of  T-TAC products.  

     In the fourth quarter of 1996, the Company presented results from the 
International Multicenter Study of Falloposcopy of its STARRT Falloposcopy 
system.  Study data showed that use of the STARRT system altered infertility 
diagnosis in the majority of cases versus conventional infertility diagnosis. 
The Company is developing a second generation STARRT catheter designed to 
improve the performance of the STARRT system.

                                       7
<PAGE>

     On November 26, 1996, the Company completed the acquisition of Microgyn, 
Inc. ("Microgyn") a privately held medical device company developing products 
designed to improve the safety and performance of resectoscope procedures, 
including therapeutic hysteroscopy.  The Company acquired all of the 
outstanding common stock of Microgyn in exchange for $3.0 million in cash on 
the acquisition date and $1.0 million in cash or stock (at the option of 
Conceptus) payable six months after the acquisition date, plus $752,000 due 
to assumption of certain liabilities and related acquisition expenses. In May 
1997, the Company satisfied the $1.0 million accrued acquisition cost by 
issuing 104,708 shares of common stock.  Additional contingent consideration 
in cash or stock, at the option of Conceptus, is payable to the former 
shareholders of Microgyn based upon meeting certain future milestones.  The 
Company is continuing product development, clinical and marketing activities, 
and is pursuing additional regulatory clearance on products acquired in the 
acquisition.  The Company recently announced the international launch of the 
ERA (Endometrial Resection and Ablation) Resectoscope Sheath, a product 
initially developed by Microgyn.

     Certain of the Company's products are currently manufactured by certain 
original equipment manufacturers while others are manufactured by Conceptus 
at its location in San Carlos, California.  If the T-TAC, STARRT, and 
Hysteroscopy products are successful, the Company expects to increase its 
direct manufacturing operations in order to better control product costs and 
increase gross margin.  Future revenues and results of operations may 
fluctuate significantly from quarter to quarter and will depend upon, among 
other factors, actions relating to regulatory and reimbursement matters, the 
extent to which the Company's products gain market acceptance, the rate at 
which the Company establishes its domestic and international distribution 
network, the timing and size of distributor purchases, the progress of 
clinical trials, and the introduction of competitive products for diagnosis 
and treatment of the female reproductive system.  

RESULTS OF OPERATIONS - THREE AND SIX MONTHS ENDED JUNE 30, 1997 AND 1996

     Sales increased to $424,000 and $701,000 for the three and six months 
ended June 30, 1997, respectively, from $105,000 and $187,000 for the same 
respective periods in the prior year.  The  increase is primarily due to 
shipments of the Company's T-TAC products to a significant U.S. distributor.  
It is anticipated that this distributor will purchase significantly lower 
levels of product in the second half of 1997.  Domestic sales comprised 87% 
and 88% of sales for the three and six month periods ended June 30, 1997, 
respectively, compared with 66% and 55% in the prior year periods.

     Cost of sales increased to $752,000 and $1,194,000 for the three and six 
months ended June 30, 1997, respectively, from $235,000 and $394,000 for same 
periods in the prior year. This increase is due to increased unit shipments 
in the current period of the Company's T-TAC products, combined with higher 
manufacturing overhead due to an increase in headcount and facilities related 
expenditures, as well as additional inventory reserves and adjustments.

     Research and development ("R&D") expenses, which include clinical and 
regulatory expenses, increased to $1,411,000 and $2,969,000 for the three and 
six months ended June 30, 1997, respectively, from $915,000 and $1,703,000 
for the same respective periods in the prior year. This increase is primarily 
due to on-going development activities on products acquired in the 
acquisition of Microgyn, an increased number of R&D employees and related 
personnel expenses as well as increased expenses associated with supporting 
various clinical and regulatory efforts.  The Company believes that its 
investment in product development is an essential element of its efforts to 
establish its competitive

                                       8
<PAGE>


position and to continue the development of future products.  Accordingly, 
the Company expects to continue to make substantial expenditures on product 
development and to increase the dollar amount expended for R&D.

     Selling, general and administrative ("SG&A") expenses increased to 
$1,483,000 and $3,048,000 for the three and six months ended June 30, 1997, 
respectively, from $1,200,000 and $2,192,000 for the same respective periods 
in the prior year. This increase is primarily due to an increase in headcount 
to support planned internal growth, as well as increased costs of being a 
public company. The Company anticipates that the dollar amount expended for 
SG&A will continue to increase, primarily due to expenses associated with 
increasing the size of the domestic sales force, and introducing and 
marketing the Company's products, which will require increased physician 
training.

     Net interest and other income decreased to $444,000 and $936,000 for the 
three and six months ended June 30, 1997, respectively, from $616,000 and 
$1,008,000 for the same respective periods in the prior year.  The decrease 
is due to a lower average invested cash balance as the proceeds of the 
Company's initial public offering of common stock on February 1, 1996 have 
been utilized during 1996 and 1997.  Interest expense for the three and six 
months ended June 30, 1997 and the amount for the same respective periods in 
the prior year was immaterial.

     As a result of the items discussed above, net loss increased to 
$2,778,000 and $5,574,000 for the three and six months ended June 30, 1997, 
respectively, from $1,629,000 and $3,094,000 for the same respective periods 
in 1996.

     The Company has a limited history of operations.  Since its inception in 
September 1992, the Company has been engaged primarily in research and 
development of its T-TAC and STARRT Falloposcopy systems and tubal 
sterilization products.  The Company has generated only limited revenues, 
primarily from sales in international markets for clinical trials, and to 
domestic and international distributors, and does not have experience in 
manufacturing, marketing or selling its products in commercial quantities.  
The Company has experienced significant operating losses since inception and, 
as of June 30, 1997, had an accumulated deficit of $29.2 million.  The 
Company expects its operating losses to continue for at least the next 
several years as it continues to expend substantial resources in funding 
clinical trials in support of regulatory and reimbursement approvals, 
expansion of manufacturing, marketing and sales activities and research and 
product development or acquisition.  Due to the expense and unpredictable 
nature of these activities, there can be no assurance that the Company will 
achieve or sustain profitability in the future.

LIQUIDITY AND CAPITAL RESOURCES

     Since inception, the Company's cash expenditures have significantly 
exceeded its sales, resulting in an accumulated deficit of $29.2 million at 
June 30, 1997.  On February 1, 1996, the Company completed an initial public 
offering of 3,450,000 shares of its common stock at $14.00 per share for net 
proceeds of $44.1 million.  Prior to the initial public offering, the Company 
funded its operations since incorporation primarily through the private 
placement of equity securities, as well as through interest income, equipment 
financing and secured loan arrangements.  Through December 31, 1996, the 
Company raised approximately $16.6 million from the private placement of 
equity securities.

                                       9
<PAGE>

     At June 30, 1997, Conceptus had cash, cash equivalents and investments 
of $32.6 million, compared with $39.0 million at December 31, 1996.  The 
decrease is due to approximately $5.7 million used in operating activities.   
Capital expenditures in the first half of 1997 increased to $710,000 from 
$188,000 in the prior year period and is largely due to expenditures for a 
new enterprise computer system and expenditures necessary to support the 
growth in employees. 

     Conceptus believes that its existing capital resources will be 
sufficient to fund its operations through 1998.  However, the Company's 
future liquidity and capital requirements will depend upon numerous factors, 
including the progress of the Company's clinical research and product 
development programs, the receipt of and the time required to obtain 
regulatory clearances and approvals, and the resources the Company devotes to 
developing, manufacturing and marketing its products.  The Company's capital 
requirements will also depend on, among other things, the resources required 
to hire and develop a direct sales force in the United States, the resources 
required to expand manufacturing capacity and facilities requirements and the 
extent to which the Company's products generate market acceptance and demand. 
 In addition, the Company may use its capital resources to acquire products, 
technologies or companies.  Accordingly, there can be no assurance that the 
Company will not require additional financing within this time frame and, 
therefore, may in the future seek to raise additional funds through bank 
facilities, debt or equity offerings or other sources of capital.  Additional 
funding may not be available when needed or on terms acceptable to the 
Company, which would have a material adverse effect on the Company's 
business, financial condition and results of operations.  

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     Not applicable.

                                       10
<PAGE>

                             PART II.  OTHER INFORMATION
                                          
                                          

ITEM 1.  LEGAL PROCEEDINGS

     None.

ITEM 2.  CHANGES IN SECURITIES

     None.

ITEM 3.  DEFAULTS IN SENIOR SECURITIES

     None.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     (a)  At the Annual Meeting of Stockholders of the Registrant, held on 
     May 13, 1997, the stockholders approved the following proposals by the 
     votes indicated below.

     (b)  Not applicable.
  
     (c)  Voting:

          (1)  Election of Directors:
    
      NOMINEE                                           FOR           WITHHELD
      -------                                           ---           --------
Richard D. Randall                                   7,185,442        139,409
Kathryn A. Tunstall                                  7,185,342        139,509
Sanford Fitch                                        7,185,342        139,509
Robert F. Kuhling                                    7,185,442        139,409
Thomas C. McConnell                                  7,185,442        139,409
Nancy S. Olson                                       7,185,442        139,409
    
          (2)  To approve and ratify the amendments to the Registrant's 1993 
          Stock Plan to increase the number of shares of Common Stock reserved 
          for issuance thereunder by 1,000,000 shares to an aggregate of 
          2,575,000 shares and to implement certain other changes resulting from
          applicable law:
    
   FOR                    AGAINST         ABSTAIN           BROKER NON-VOTES
   ---                    -------         -------           ----------------
4,898,130                 653,069          4,825               1,763,137
                                          
          (3)  To ratify the appointment of Ernst & Young LLP as the 
          Registrant's independent auditors for the fiscal year ending 
          December 31, 1997:
    
   FOR                    AGAINST         ABSTAIN           BROKER NON-VOTES
   ---                    -------         -------           ----------------
7,306,302                  1,359           11,450                  0

                                       11
<PAGE>



ITEM 5.  OTHER INFORMATION

     None.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

 
     (a)  Exhibits

            10.18    Change of Control Agreement dated as of May 13, 1997 by 
                     and between Registrant and Kathryn A. Tunstall.
 
            10.19    Change of Control Agreement dated as of May 13, 1997 by 
                     and between Registrant and Sanford Fitch.

            10.20    Form of Senior Management Change of Control Agreement.

            27       Financial Data Schedule.
    
  

     (b)  Reports on Form 8-K.

          One Report on Form 8-K was filed on July 25, 1997 reporting a press 
          release announcing the commencement of international sales of the ERA 
          (Endometrial Resection and Ablation) Resectoscope Sheath and a press 
          release announcing the financial results for the second quarter ended 
          June 30, 1997, under Item 5 of Form 8-K.

                                       12
<PAGE>


                                     SIGNATURES
                                          
     Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this Report to be signed on its behalf by the 
undersigned, thereunto duly authorized.

                                       CONCEPTUS, INC.


                                       By: /s/ SANFORD FITCH
                                          --------------------------------------
                                                      Sanford Fitch
                                                  Senior Vice President
                                               and Chief Financial Officer
                                        (Duly Authorized and Principal Financial
                                                   and Accounting Officer)


Date:  August 14, 1997


                                       13
<PAGE>

                                 INDEX TO EXHIBITS
                                          
                                          
EXHIBIT 
NUMBER                                DESCRIPTION
- -------                               -----------

10.18     Change of Control Agreement dated as of May 13, 
          1997 by and between Registrant and Kathryn A. 
          Tunstall.
 
10.19     Change of Control Agreement dated as of May 13, 
          1997 by and between Registrant and Sanford Fitch.
 
10.20     Form of Senior Management Change of Control 
          Agreement.
 
 27       Financial Data Schedule

                                       14

<PAGE>
                                 EXHIBIT 10.18
                                       
                          CHANGE OF CONTROL AGREEMENT
                                       


     This Change of Control Agreement (the "Agreement") is made and entered
into effective as of May 13, 1997, by and between Kathryn A. Tunstall (the
"Employee") and Conceptus, Inc., a Delaware corporation (the "Company").


                                   RECITALS

     A.   It is expected that another company or other entity may from time to
time consider the possibility of acquiring the Company or that a change in
control may otherwise occur, with or without the approval of the Company's
Board of Directors (the "Board").  The Board recognizes that such consideration
can be a distraction to the Employee, an executive officer of the Company, and
can cause the Employee to consider alternative employment opportunities.  The
Board has determined that it is in the best interests of the Company and its
stockholders to assure that the Company will have the continued dedication and
objectivity of the Employee, notwithstanding the possibility, threat or
occurrence of a Change of Control (as defined below) of the Company.

     B.   The Board believes that it is in the best interests of the Company
and its stockholders to provide the Employee with an incentive to continue his
or her employment with the Company.

     C.   The Board believes that it is imperative to provide the Employee with
certain benefits upon a Change of Control and, under certain circumstances,
upon termination of the Employee's employment in connection with a Change of
Control, which benefits are intended to provide the Employee with financial
security and provide sufficient income and encouragement to the Employee to
remain with the Company notwithstanding the possibility of a Change of Control.

     D.   To accomplish the foregoing objectives, the Board of Directors has
directed the Company, upon execution of this Agreement by the Employee, to
agree to the terms provided in this Agreement.

     E.   Certain capitalized terms used in the Agreement are defined in
Section 4 below.

     In consideration of the mutual covenants contained in this Agreement, and
in consideration of the continuing employment of Employee by the Company, the
parties agree as follows:

          1.   AT-WILL EMPLOYMENT.  The Company and the Employee acknowledge 
that the Employee's employment is and shall continue to be at-will, as 
defined under 

                                       -1-
<PAGE>

applicable law.  If the Employee's employment terminates for any reason, 
including (without limitation) any termination prior to a Change of Control, 
the Employee shall not be entitled to any payments or benefits, other than as 
provided by this Agreement, or as may otherwise be available in accordance 
with the terms of the Company's then existing employee plans and written 
policies in effect at the time of termination.  The terms of this Agreement 
shall terminate upon the earlier of (i) the date on which Employee ceases to 
be employed as an executive officer of the Company, other than as a result of 
an involuntary termination by the Company without Cause (ii) the date that 
all obligations of the parties hereunder have been satisfied, or (iii) two 
(2) years after a Change of Control.  A termination of the terms of this 
Agreement pursuant to the preceding sentence shall be effective for all 
purposes, except that such termination shall not affect the payment or 
provision of compensation or benefits on account of a termination of 
employment occurring prior to the termination of the terms of this Agreement.

          2.   STOCK OPTIONS.  Subject to Sections 5 and 6 below, in the event
of a Change of Control and regardless of whether Employee's employment with the
Company is terminated in connection with the Change of Control, each stock
option granted for the Company's securities held by the Employee shall become
fully vested and immediately exercisable on the effective date of the
transaction and shall be exercisable to the extent so vested in accordance with
the provisions of the Stock Option Agreement and Stock Option Plan pursuant to
which such stock option was granted.

          3.   CHANGE OF CONTROL.

               (a)  TERMINATION FOLLOWING A CHANGE OF CONTROL.  Subject to
Section 5 and 6 below, if the Employee's employment with the Company is
terminated at any time within two (2) years after a Change of Control, then the
Employee shall be entitled to receive severance benefits as follows:

                    (i)   VOLUNTARY RESIGNATION.  If the Employee voluntarily 
resigns from the Company (other than as an Involuntary Termination (as 
defined below) or if the Company terminates the Employee's employment for 
Cause (as defined below)), then the Employee shall not be entitled to receive 
severance payments.  The Employee's benefits will be terminated under the 
terms of the Company's then existing benefit plans and policies in accordance 
with such plans and policies in effect on the date of termination or as 
otherwise determined by the Board of Directors of the Company.

                    (ii)  INVOLUNTARY TERMINATION.  If the Employee's 
employment is terminated as a result of an Involuntary Termination other than 
for Cause, the Employee shall be entitled to receive the following benefits: 
(i) severance payments during the period from the date of the Employee's 
termination until the date 18 months after the effective date of the 
termination (the "Severance Period") equal to the salary which the Employee 
was receiving at the time of such termination, which payments shall be paid 
during the Severance Period in accordance with the Company's standard payroll 
practices; (ii) monthly severance payments during the Severance Period equal 
to 1/12th of the Employee's "target bonus" (as defined below) for the fiscal 
year in which the termination 

                                       -2-
<PAGE>

occurs (or for the prior fiscal year if a target bonus has not yet been 
determined for the fiscal year in which the termination occurs); (iii) 
continuation of all health and life insurance benefits through the end of the 
Severance Period substantially identical to those to which the Employee was 
entitled immediately prior to the termination, or to those being offered to 
officers of the Company, or a successor corporation, if the Company's benefit 
programs are changed during the Severance Period; and (iv) outplacement 
services with a total value not to exceed $15,000.  For purposes of this 
Agreement, the term "target bonus" shall mean the Employee's base salary in 
effect on the termination date multiplied by that percentage of such base 
salary that is prescribed by the Company under its Executive Bonus Program as 
the percentage of such base salary payable to the Employee as a bonus if the 
Company pays bonuses at one-hundred percent (100%) of its operating plan.

                    (iii) INVOLUNTARY TERMINATION FOR CAUSE.  If the 
Employee's employment is terminated for Cause, then the Employee shall not be 
entitled to receive severance payments.  The Employee's benefits will be 
terminated under the Company's then existing benefit plans and policies in 
accordance with such plans and policies in effect on the date of termination.

               (b)  TERMINATION APART FROM A CHANGE OF CONTROL.  In the event 
the Employee's employment terminates for any reason, either prior to the 
occurrence of a Change of Control or after the two year period following the 
effective date of a Change of Control, then the Employee shall not be 
entitled to receive any severance payments under this Agreement.  The 
Employee's benefits will be terminated under the terms of the Company's then 
existing benefit plans and policies in accordance with such plans and 
policies in effect on the date of termination or as otherwise determined by 
the Board of Directors of the Company.

          4.   DEFINITION OF TERMS.  The following terms referred to in this 
Agreement shall have the following meanings:

               (a)  CHANGE OF CONTROL.  "Change of Control" shall mean the 
occurrence of any of the following events:

                    (i)   OWNERSHIP.  Any "Person" (as such term is used in 
Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) 
is or becomes the "Beneficial Owner" (as defined in Rule 13d-3 under said 
Act), directly or indirectly, of securities of the Company representing 
twenty percent (20%) or more of the total voting power represented by the 
Company's then outstanding voting securities WITHOUT the approval of the 
Board of Directors of the Company; or

                    (ii)  MERGER/SALE OF ASSETS.  A merger or consolidation 
of the Company whether or not approved by the Board of Directors of the 
Company, other than a merger or consolidation which would result in the 
voting securities of the Company outstanding immediately prior thereto 
continuing to represent (either by remaining outstanding or by being 
converted into voting securities of the surviving entity) at least fifty 
percent (50%) of the total voting power represented by the voting securities 
of the Company or such surviving entity outstanding immediately after such 
merger or consolidation, or the 

                                       -3-
<PAGE>

stockholders of the Company approve a plan of complete liquidation of the 
Company or an agreement for the sale or disposition by the Company of all or 
substantially all of the Company's assets.

                    (iii) CHANGE IN BOARD COMPOSITION.  A change in the 
composition of the Board of Directors of the Company, as a result of which 
fewer than a majority of the directors are Incumbent Directors.  "Incumbent 
Directors" shall mean directors who either (A) are directors of the Company 
as of May 13, 1997 or (B) are elected, or nominated for election, to the 
Board of Directors of the Company with the affirmative votes of at least a 
majority of the Incumbent Directors at the time of such election or 
nomination (but shall not include an individual whose election or nomination 
is in connection with an actual or threatened proxy contest relating to the 
election of directors to the Company).

               (b)  CAUSE.  "Cause" shall mean (i) gross negligence or 
willful misconduct in the performance of the Employee's duties to the Company 
where such gross negligence or willful misconduct has resulted or is likely 
to result in substantial and material damage to the Company or its 
subsidiaries, (ii) repeated unexplained or unjustified absence from the 
Company, (iii) a material and willful violation of any federal or state law; 
(iv) commission of any act of fraud with respect to the Company; or (v) 
conviction of a felony or a crime involving moral turpitude causing material 
harm to the standing and reputation of the Company, in each case as 
determined in good faith by the Board of Directors of the Company.

               (c)  INVOLUNTARY TERMINATION.  "Involuntary Termination" shall 
include any termination by the Company other than for Cause and the 
Employee's voluntary termination, upon 30 days prior written notice to the 
Company, following (i)  any reduction of the Employee's base compensation 
(other than in connection with a general decrease in base salaries for most 
similarly situated employees of the successor corporation); or (ii) the 
Employee's refusal to relocate to a location more than 50 miles from the 
Company's current location.

          5.   LIMITATION ON PAYMENTS.  To the extent that any of the 
payments or benefits provided for in this Agreement to the Employee 
constitute "parachute payments" within the meaning of Section 280G of the 
Internal Revenue Code of 1986, as amended (the "Code") and, but for this 
Section 5, would be subject to the excise tax imposed by Section 4999 of the 
Code, the Company shall reduce the aggregate amount of such payments and 
benefits such that the present value thereof (as determined under the Code 
and the applicable regulations) is equal to 2.99 times the Employee's "base 
amount" as defined in Section 280G(b)(3) of the Code.

          6.   CERTAIN BUSINESS COMBINATIONS.  In the event it is determined 
by the Board, upon consultation with Company management and the Company's 
independent auditors, that the enforcement of any Section of this Agreement, 
including, but not limited to, Section 2 hereof, which allows for the 
acceleration of vesting of option shares upon the effective date of a Change 
of Control, would preclude accounting for any proposed business combination 
of the Company involving a Change of Control as a pooling of interests, and 
the 

                                       -4-
<PAGE>

Board otherwise desires to approve such a proposed business transaction which 
requires as a condition to the closing of such transaction that it be 
accounted for as a pooling of interests, then any such Section of this 
Agreement shall be null and void.  For purposes of this Section 6, the 
Board's determination shall require the unanimous approval of the 
non-employee Board members.

          7.   SUCCESSORS.  Any successor to the Company (whether direct or 
indirect and whether by purchase, lease, merger, consolidation, liquidation 
or otherwise) to all or substantially all of the Company's business and/or 
assets shall assume the obligations under this Agreement and agree expressly 
to perform the obligations under this Agreement in the same manner and to the 
same extent as the Company would be required to perform such obligations in 
the absence of a succession.  The terms of this Agreement and all of the 
Employee's rights hereunder shall inure to the benefit of, and be enforceable 
by, the Employee's personal or legal representatives, executors, 
administrators, successors, heirs, distributees, devisees and legatees.

          8.   NOTICE.  Notices and all other communications contemplated by 
this Agreement shall be in writing and shall be deemed to have been duly 
given when personally delivered or when mailed by U.S. registered or 
certified mail, return receipt requested and postage prepaid.  Mailed notices 
to the Employee shall be addressed to the Employee at the home address which 
the Employee most recently communicated to the Company in writing.  In the 
case of the Company, mailed notices shall be addressed to its corporate 
headquarters, and all notices shall be directed to the attention of its 
Secretary.

          9.   MISCELLANEOUS PROVISIONS.

               (a)  NO DUTY TO MITIGATE.  The Employee shall not be required 
to mitigate the amount of any payment contemplated by this Agreement (whether 
by seeking new employment or in any other manner), nor, except as otherwise 
provided in this Agreement, shall any such payment be reduced by any earnings 
that the Employee may receive from any other source.

               (b)  WAIVER.  No provision of this Agreement shall be 
modified, waived or discharged unless the modification, waiver or discharge 
is agreed to in writing and signed by the Employee and by an authorized 
officer of the Company (other than the Employee).  No waiver by either party 
of any breach of, or of compliance with, any condition or provision of this 
Agreement by the other party shall be considered a waiver of any other 
condition or provision or of the same condition or provision at another time.

               (c)  WHOLE AGREEMENT.  No agreements, representations or 
understandings (whether oral or written and whether express or implied) which 
are not expressly set forth in this Agreement have been made or entered into 
by either party with respect to the subject matter hereof.  This Agreement 
supersedes any agreement of the same title and concerning similar subject 
matter dated prior to the date of this Agreement, and by execution of this 
Agreement both parties agree that any such predecessor agreement shall be 
deemed null and void.

                                       -5-
<PAGE>

               (d)  CHOICE OF LAW.  The validity, interpretation, 
construction and performance of this Agreement shall be governed by the laws 
of the State of California without reference to conflict of laws provisions.

               (e)  SEVERABILITY.  If any term or provision of this Agreement 
or the application thereof to any circumstance shall, in any jurisdiction and 
to any extent, be invalid or unenforceable, such term or provision shall be 
ineffective as to such jurisdiction to the extent of such invalidity or 
unenforceability without invalidating or rendering unenforceable the 
remaining terms and provisions of this Agreement or the application of such 
terms and provisions to circumstances other than those as to which it is held 
invalid or unenforceable, and a suitable and equitable term or provision 
shall be substituted therefor to carry out, insofar as may be valid and 
enforceable, the intent and purpose of the invalid or unenforceable term or 
provision.

               (f)  ARBITRATION.  Any dispute or controversy arising under or 
in connection with this Agreement may be settled at the option of either 
party by binding arbitration in the County of Santa Clara, California, in 
accordance with the rules of the American Arbitration Association then in 
effect. Judgment may be entered on the arbitrator's  award in any court 
having jurisdiction.  Punitive damages shall not be awarded.

               (g)  LEGAL FEES AND EXPENSES.  The parties shall each bear 
their own expenses, legal fees and other fees incurred in connection with 
this Agreement.

               (h)  NO ASSIGNMENT OF BENEFITS.  The rights of any person to 
payments or benefits under this Agreement shall not be made subject to option 
or assignment, either by voluntary or involuntary assignment or by operation 
of law, including (without limitation) bankruptcy, garnishment, attachment or 
other creditor's process, and any action in violation of this subsection (h) 
shall be void.

               (i)  EMPLOYMENT TAXES.  All payments made pursuant to this 
Agreement will be subject to withholding of applicable income and employment 
taxes.

               (j)  ASSIGNMENT BY COMPANY.  The Company may assign its rights 
under this Agreement to an affiliate, and an affiliate may assign its rights 
under this Agreement to another affiliate of the Company or to the Company; 
provided, however, that no assignment shall be made if the net worth of the 
assignee is less than the net worth of the Company at the time of assignment. 
In the case of any such assignment, the term "Company" when used in a section 
of this Agreement shall mean the corporation that actually employs the 
Employee.

               (k)  COUNTERPARTS.  This Agreement may be executed in 
counterparts, each of which shall be deemed an original, but all of which 
together will constitute one and the same instrument.

                                       -6-
<PAGE>

     IN WITNESS WHEREOF, each of the parties has executed this Agreement, in 
the case of the Company by its duly authorized officer, as of the day and 
year first above written.

CONCEPTUS, INC.                         KATHRYN A. TUNSTALL


By: Sanford Fitch                       /s/ Kathryn A. Tunstall
   --------------------------------     --------------------------------     

Title: Senior Vice President and Chief Financial Officer
      --------------------------------------------------


                                       -7-

<PAGE>
                                 EXHIBIT 10.19
                                       
                          CHANGE OF CONTROL AGREEMENT
                                       
     
     
     This Change of Control Agreement (the "Agreement") is made and entered 
into effective as of May 13, 1997, by and between Sanford Fitch (the 
"Employee") and Conceptus, Inc., a Delaware corporation (the "Company").

                                   RECITALS

     A.   It is expected that another company or other entity may from time 
to time consider the possibility of acquiring the Company or that a change in 
control may otherwise occur, with or without the approval of the Company's 
Board of Directors (the "Board").  The Board recognizes that such 
consideration can be a distraction to the Employee, an executive corporate 
officer of the Company, and can cause the Employee to consider alternative 
employment opportunities.  The Board has determined that it is in the best 
interests of the Company and its stockholders to assure that the Company will 
have the continued dedication and objectivity of the Employee, 
notwithstanding the possibility, threat or occurrence of a Change of Control 
(as defined below) of the Company.

     B.   The Board believes that it is in the best interests of the Company 
and its stockholders to provide the Employee with an incentive to continue 
his or her employment with the Company.

     C.   The Board believes that it is imperative to provide the Employee 
with certain benefits upon a Change of Control and, under certain 
circumstances, upon termination of the Employee's employment in connection 
with a Change of Control, which benefits are intended to provide the Employee 
with financial security and provide sufficient income and encouragement to 
the Employee to remain with the Company notwithstanding the possibility of a 
Change of Control.

     D.   To accomplish the foregoing objectives, the Board of Directors has 
directed the Company, upon execution of this Agreement by the Employee, to 
agree to the terms provided in this Agreement.

     E.   Certain capitalized terms used in the Agreement are defined in 
Section 4 below.

     In consideration of the mutual covenants contained in this Agreement, 
and in consideration of the continuing employment of Employee by the Company, 
the parties agree as follows:

          1.   AT-WILL EMPLOYMENT.  The Company and the Employee acknowledge
that the Employee's employment is and shall continue to be at-will, as defined
under 

                                       -1-
<PAGE>

applicable law.  If the Employee's employment terminates for any reason, 
including (without limitation) any termination prior to a Change of Control, 
the Employee shall not be entitled to any payments or benefits, other than as 
provided by this Agreement, or as may otherwise be available in accordance 
with the terms of the Company's then existing employee plans and written 
policies in effect at the time of termination.  The terms of this Agreement 
shall terminate upon the earlier of (i) the date on which Employee ceases to 
be employed as an executive officer of the Company, other than as a result of 
an involuntary termination by the Company without Cause (ii) the date that 
all obligations of the parties hereunder have been satisfied, or (iii) two 
(2) years after a Change of Control.  A termination of the terms of this 
Agreement pursuant to the preceding sentence shall be effective for all 
purposes, except that such termination shall not affect the payment or 
provision of compensation or benefits on account of a termination of 
employment occurring prior to the termination of the terms of this Agreement.

          2.   STOCK OPTIONS.  Subject to Sections 5 and 6 below, in the 
event of a Change of Control and regardless of whether the Employee's 
employment with the Company is terminated in connection with the Change of 
Control, each stock option granted for the Company's securities held by the 
Employee shall become fully vested and immediately exercisable on the 
effective date of the transaction and shall be exercisable to the extent so 
vested in accordance with the provisions of the Stock Option Agreement and 
Stock Option Plan pursuant to which such stock option was granted.

          3.   CHANGE OF CONTROL.

               (a)  TERMINATION FOLLOWING A CHANGE OF CONTROL.  Subject to 
Section 5 and 6 below, if the Employee's employment with the Company is 
terminated at any time within two (2) years after a Change of Control, then 
the Employee shall be entitled to receive severance benefits as follows:

                    (i)   VOLUNTARY RESIGNATION.  If the Employee voluntarily 
resigns from the Company (other than as an Involuntary Termination (as 
defined below) or if the Company terminates the Employee's employment for 
Cause (as defined below)), then the Employee shall not be entitled to receive 
severance payments.  The Employee's benefits will be terminated under the 
terms of the Company's then existing benefit plans and policies in accordance 
with such plans and policies in effect on the date of termination or as 
otherwise determined by the Board of Directors of the Company.

                    (ii)  INVOLUNTARY TERMINATION.  If the Employee's 
employment is terminated as a result of an Involuntary Termination other than 
for Cause, the Employee shall be entitled to receive the following benefits: 
(i) severance payments during the period from the date of the Employee's 
termination until the date 12 months after the effective date of the 
termination (the "Severance Period") equal to the salary which the Employee 
was receiving at the time of such termination, which payments shall be paid 
during the Severance Period in accordance with the Company's standard payroll 
practices; (ii) monthly severance payments during the Severance Period equal 
to 1/12th of the Employee's "target bonus" (as defined below) for the fiscal 
year in which the termination 

                                       -2-
<PAGE>

occurs (or for the prior fiscal year if a target bonus has not yet been 
determined for the fiscal year in which the termination occurs); (iii) 
continuation of all health and life insurance benefits through the end of the 
Severance Period substantially identical to those to which the Employee was 
entitled immediately prior to the termination, or to those being offered to 
officers of the Company, or a successor corporation, if the Company's benefit 
programs are changed during the Severance Period; and (iv) outplacement 
services with a total value not to exceed $15,000.  For purposes of this 
Agreement, the term "target bonus" shall mean the Employee's base salary in 
effect on the termination date multiplied by that percentage of such base 
salary that is prescribed by the Company under its Executive Bonus Program as 
the percentage of such base salary payable to the Employee as a bonus if the 
Company pays bonuses at one-hundred percent (100%) of its operating plan.

                    (iii) INVOLUNTARY TERMINATION FOR CAUSE.  If the 
Employee's employment is terminated for Cause, then the Employee shall not be 
entitled to receive severance payments.  The Employee's benefits will be 
terminated under the Company's then existing benefit plans and policies in 
accordance with such plans and policies in effect on the date of termination.

               (b)  TERMINATION APART FROM A CHANGE OF CONTROL.  In the event 
the Employee's employment terminates for any reason, either prior to the 
occurrence of a Change of Control or after the two year period following the 
effective date of a Change of Control, then the Employee shall not be 
entitled to receive any severance payments under this Agreement.  The 
Employee's benefits will be terminated under the terms of the Company's then 
existing benefit plans and policies in accordance with such plans and 
policies in effect on the date of termination or as otherwise determined by 
the Board of Directors of the Company.

          4.   DEFINITION OF TERMS.  The following terms referred to in this 
Agreement shall have the following meanings:

               (a)  CHANGE OF CONTROL.  "Change of Control" shall mean the 
occurrence of any of the following events:

                    (i)   OWNERSHIP.  Any "Person" (as such term is used in 
Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) 
is or becomes the "Beneficial Owner" (as defined in Rule 13d-3 under said 
Act), directly or indirectly, of securities of the Company representing 
twenty percent (20%) or more of the total voting power represented by the 
Company's then outstanding voting securities WITHOUT the approval of the 
Board of Directors of the Company; or

                    (ii)  MERGER/SALE OF ASSETS.  A merger or consolidation 
of the Company whether or not approved by the Board of Directors of the 
Company, other than a merger or consolidation which would result in the 
voting securities of the Company outstanding immediately prior thereto 
continuing to represent (either by remaining outstanding or by being 
converted into voting securities of the surviving entity) at least fifty 
percent (50%) of the total voting power represented by the voting securities 
of the Company or such surviving entity outstanding immediately after such 
merger or consolidation, or the 

                                       -3-
<PAGE>

stockholders of the Company approve a plan of complete liquidation of the 
Company or an agreement for the sale or disposition by the Company of all or 
substantially all of the Company's assets.

                    (iii) CHANGE IN BOARD COMPOSITION.  A change in the 
composition of the Board of Directors of the Company, as a result of which 
fewer than a majority of the directors are Incumbent Directors.  "Incumbent 
Directors" shall mean directors who either (A) are directors of the Company 
as of May 13, 1997 or (B) are elected, or nominated for election, to the 
Board of Directors of the Company with the affirmative votes of at least a 
majority of the Incumbent Directors at the time of such election or 
nomination (but shall not include an individual whose election or nomination 
is in connection with an actual or threatened proxy contest relating to the 
election of directors to the Company).

               (b)  CAUSE.  "Cause" shall mean (i) gross negligence or 
willful misconduct in the performance of the Employee's duties to the Company 
where such gross negligence or willful misconduct has resulted or is likely 
to result in substantial and material damage to the Company or its 
subsidiaries, (ii) repeated unexplained or unjustified absence from the 
Company, (iii) a material and willful violation of any federal or state law; 
(iv) commission of any act of fraud with respect to the Company; or (v) 
conviction of a felony or a crime involving moral turpitude causing material 
harm to the standing and reputation of the Company, in each case as 
determined in good faith by the Board of Directors of the Company.

               (c)  INVOLUNTARY TERMINATION.  "Involuntary Termination" shall 
include any termination by the Company other than for Cause and the 
Employee's voluntary termination, upon 30 days prior written notice to the 
Company, following (i) any reduction of the Employee's base compensation 
(other than in connection with a general decrease in base salaries for most 
similarly situated employees of the successor corporation); or (ii) the 
Employee's refusal to relocate to a location more than 50 miles from the 
Company's current location.

          5.   LIMITATION ON PAYMENTS.  To the extent that any of the 
payments or benefits provided for in this Agreement to the Employee 
constitute "parachute payments" within the meaning of Section 280G of the 
Internal Revenue Code of 1986, as amended (the "Code") and, but for this 
Section 5, would be subject to the excise tax imposed by Section 4999 of the 
Code, the Company shall reduce the aggregate amount of such payments and 
benefits such that the present value thereof (as determined under the Code 
and the applicable regulations) is equal to 2.99 times the Employee's "base 
amount" as defined in Section 280G(b)(3) of the Code.

          6.   CERTAIN BUSINESS COMBINATIONS.  In the event it is determined by
the Board, upon consultation with Company management and the Company's
independent auditors, that the enforcement of any Section of this Agreement,
including, but not limited to, Section 2 hereof, which allows for the
acceleration of vesting of option shares upon the effective date of a Change of
Control, would preclude accounting for any proposed business combination of the
Company involving a Change of Control as a pooling of interests, and the 

                                       -4-
<PAGE>

Board otherwise desires to approve such a proposed business transaction which 
requires as a condition to the closing of such transaction that it be 
accounted for as a pooling of interests, then any such Section of this 
Agreement shall be null and void.  For purposes of this Section 6, the 
Board's determination shall require the unanimous approval of the 
non-employee Board members.

          7.   SUCCESSORS.  Any successor to the Company (whether direct or 
indirect and whether by purchase, lease, merger, consolidation, liquidation 
or otherwise) to all or substantially all of the Company's business and/or 
assets shall assume the obligations under this Agreement and agree expressly 
to perform the obligations under this Agreement in the same manner and to the 
same extent as the Company would be required to perform such obligations in 
the absence of a succession.  The terms of this Agreement and all of the 
Employee's rights hereunder shall inure to the benefit of, and be enforceable 
by, the Employee's personal or legal representatives, executors, 
administrators, successors, heirs, distributees, devisees and legatees.

          8.   NOTICE.  Notices and all other communications contemplated by 
this Agreement shall be in writing and shall be deemed to have been duly 
given when personally delivered or when mailed by U.S. registered or 
certified mail, return receipt requested and postage prepaid.  Mailed notices 
to the Employee shall be addressed to the Employee at the home address which 
the Employee most recently communicated to the Company in writing.  In the 
case of the Company, mailed notices shall be addressed to its corporate 
headquarters, and all notices shall be directed to the attention of its 
Secretary.

          9.   MISCELLANEOUS PROVISIONS.

               (a)  NO DUTY TO MITIGATE.  The Employee shall not be required 
to mitigate the amount of any payment contemplated by this Agreement (whether 
by seeking new employment or in any other manner), nor, except as otherwise 
provided in this Agreement, shall any such payment be reduced by any earnings 
that the Employee may receive from any other source.

               (b)  WAIVER.  No provision of this Agreement shall be 
modified, waived or discharged unless the modification, waiver or discharge 
is agreed to in writing and signed by the Employee and by an authorized 
officer of the Company (other than the Employee).  No waiver by either party 
of any breach of, or of compliance with, any condition or provision of this 
Agreement by the other party shall be considered a waiver of any other 
condition or provision or of the same condition or provision at another time.

               (c)  WHOLE AGREEMENT.  No agreements, representations or 
understandings (whether oral or written and whether express or implied) which 
are not expressly set forth in this Agreement have been made or entered into 
by either party with respect to the subject matter hereof.  This Agreement 
supersedes any agreement of the same title and concerning similar subject 
matter dated prior to the date of this Agreement, and by execution of this 
Agreement both parties agree that any such predecessor agreement shall be 
deemed null and void.

                                       -5-
<PAGE>

               (d)  CHOICE OF LAW.  The validity, interpretation, 
construction and performance of this Agreement shall be governed by the laws 
of the State of California without reference to conflict of laws provisions.

               (e)  SEVERABILITY.  If any term or provision of this Agreement 
or the application thereof to any circumstance shall, in any jurisdiction and 
to any extent, be invalid or unenforceable, such term or provision shall be 
ineffective as to such jurisdiction to the extent of such invalidity or 
unenforceability without invalidating or rendering unenforceable the 
remaining terms and provisions of this Agreement or the application of such 
terms and provisions to circumstances other than those as to which it is held 
invalid or unenforceable, and a suitable and equitable term or provision 
shall be substituted therefor to carry out, insofar as may be valid and 
enforceable, the intent and purpose of the invalid or unenforceable term or 
provision.

               (f)  ARBITRATION.  Any dispute or controversy arising under or 
in connection with this Agreement may be settled at the option of either 
party by binding arbitration in the County of Santa Clara, California, in 
accordance with the rules of the American Arbitration Association then in 
effect. Judgment may be entered on the arbitrator's  award in any court 
having jurisdiction.  Punitive damages shall not be awarded.

               (g)  LEGAL FEES AND EXPENSES.  The parties shall each bear 
their own expenses, legal fees and other fees incurred in connection with 
this Agreement.

               (h)  NO ASSIGNMENT OF BENEFITS.  The rights of any person to 
payments or benefits under this Agreement shall not be made subject to option 
or assignment, either by voluntary or involuntary assignment or by operation 
of law, including (without limitation) bankruptcy, garnishment, attachment or 
other creditor's process, and any action in violation of this subsection (h) 
shall be void.

               (i)  EMPLOYMENT TAXES.  All payments made pursuant to this 
Agreement will be subject to withholding of applicable income and employment 
taxes.

               (j)  ASSIGNMENT BY COMPANY.  The Company may assign its rights 
under this Agreement to an affiliate, and an affiliate may assign its rights 
under this Agreement to another affiliate of the Company or to the Company; 
provided, however, that no assignment shall be made if the net worth of the 
assignee is less than the net worth of the Company at the time of assignment. 
In the case of any such assignment, the term "Company" when used in a section 
of this Agreement shall mean the corporation that actually employs the 
Employee.

               (k)  COUNTERPARTS.  This Agreement may be executed in 
counterparts, each of which shall be deemed an original, but all of which 
together will constitute one and the same instrument.

                                       -6-
<PAGE>

     IN WITNESS WHEREOF, each of the parties has executed this Agreement, in 
the case of the Company by its duly authorized officer, as of the day and 
year first above written.

CONCEPTUS, INC.                         SANFORD FITCH


By: Kathryn A. Tunstall                 /s/ Sanford Fitch
   --------------------------------     --------------------------------     

Title: President and Chief Executive Officer
      ----------------------------------------


                                       -7-

<PAGE>
                                 EXHIBIT 10.20
                                       
                           FORM OF SENIOR MANAGEMENT
                          CHANGE OF CONTROL AGREEMENT
                                       


     This Change of Control Agreement (the "Agreement") is made and entered 
into effective as of May 13, 1997, by and between Employee (the "Employee") 
and Conceptus, Inc., a Delaware corporation (the "Company").

                                   RECITALS

     A.   It is expected that another company or other entity may from time 
to time consider the possibility of acquiring the Company or that a change in 
control may otherwise occur, with or without the approval of the Company's 
Board of Directors (the "Board").  The Board recognizes that such 
consideration can be a distraction to the Employee, an executive officer or 
director-level employee of the Company, and can cause the Employee to 
consider alternative employment opportunities.  The Board has determined that 
it is in the best interests of the Company and its stockholders to assure 
that the Company will have the continued dedication and objectivity of the 
Employee, notwithstanding the possibility, threat or occurrence of a Change 
of Control (as defined below) of the Company.

     B.   The Board believes that it is in the best interests of the Company 
and its stockholders to provide the Employee with an incentive to continue 
his or her employment with the Company.

     C.   The Board believes that it is imperative to provide the Employee 
with certain benefits upon a Change of Control and, under certain 
circumstances, upon termination of the Employee's employment in connection 
with a Change of Control, which benefits are intended to provide the Employee 
with financial security and provide sufficient income and encouragement to 
the Employee to remain with the Company notwithstanding the possibility of a 
Change of Control.

     D.   To accomplish the foregoing objectives, the Board of Directors has 
directed the Company, upon execution of this Agreement by the Employee, to 
agree to the terms provided in this Agreement.

     E.   Certain capitalized terms used in the Agreement are defined in 
Section 4 below.

     In consideration of the mutual covenants contained in this Agreement, 
and in consideration of the continuing employment of Employee by the Company, 
the parties agree as follows:

                                       -1-
<PAGE>

          1.   AT-WILL EMPLOYMENT.  The Company and the Employee acknowledge 
that the Employee's employment is and shall continue to be at-will, as 
defined under applicable law.  If the Employee's employment terminates for 
any reason, including (without limitation) any termination prior to a Change 
of Control, the Employee shall not be entitled to any payments or benefits, 
other than as provided by this Agreement, or as may otherwise be available in 
accordance with the terms of the Company's then existing employee plans and 
written policies in effect at the time of termination.  The terms of this 
Agreement shall terminate upon the earlier of (i) the date on which Employee 
ceases to be employed as an executive officer or director-level employee of 
the Company, other than as a result of an involuntary termination by the 
Company without Cause (ii) the date that all obligations of the parties 
hereunder have been satisfied, or (iii) two (2) years after a Change of 
Control.  A termination of the terms of this Agreement pursuant to the 
preceding sentence shall be effective for all purposes, except that such 
termination shall not affect the payment or provision of compensation or 
benefits on account of a termination of employment occurring prior to the 
termination of the terms of this Agreement.

          2.   STOCK OPTIONS.

               (a)  HOSTILE TAKEOVER.  Subject to Sections 5 and 6 below, in 
the event of a Hostile Takeover and regardless of whether the Employee's 
employment with the Company is terminated in connection with the Hostile 
Takeover, each stock option granted for the Company's securities (the 
"Option") held by the Employee shall become fully vested and immediately 
exercisable on the effective date of the transaction and shall be exercisable 
to the extent so vested in accordance with the provisions of the Stock Option 
Agreement and Stock Option Plan pursuant to which such Option was granted.

               (b)  CHANGE OF CONTROL.  Subject to Sections 5 and 6 below, in 
the event of a Change of Control and regardless of whether the Employee's 
employment with the Company is terminated in connection with the Change of 
Control, each Option held by the Employee shall become vested on the 
effective date of the transaction as to fifty percent (50%) of the Option 
shares that have not otherwise vested as of such date.  The Option shares 
that remain unvested as of the effective date of the transaction shall 
thereafter vest at the same rate (that is, the same number of shares shall 
vest during each vesting period) that was in effect prior to the Change of 
Control, and shall accordingly vest over a period that is one-half of the 
total vesting period that would otherwise be then remaining under the terms 
of the Option Agreement pursuant to which each such Option was granted.

          3.   CHANGE OF CONTROL.

               (a)  TERMINATION FOLLOWING A CHANGE OF CONTROL.  Subject to 
Sections 5 and 6 below, if the Employee's employment with the Company is 
terminated at any time within two (2) years after a Change of Control, then 
the Employee shall be entitled to receive severance benefits as follows:

                    (i)   VOLUNTARY RESIGNATION.  If the Employee voluntarily 
resigns from the Company (other than as an Involuntary Termination (as 
defined below) or if 

                                       -2-
<PAGE>

the Company terminates the Employee's employment for Cause (as defined 
below)), then the Employee shall not be entitled to receive severance 
payments.  The Employee's benefits will be terminated under the Company's 
then existing benefit plans and policies in accordance with such plans and 
policies in effect on the date of termination or as otherwise determined by 
the Board of Directors of the Company.

                    (ii)  INVOLUNTARY TERMINATION.  If the Employee's 
employment is terminated as a result of an Involuntary Termination other than 
for Cause, the Employee shall be entitled to receive the following benefits: 
(i) severance payments during the period from the date of the Employee's 
termination until the date 12 months after the effective date of the 
termination (the "Severance Period") equal to the salary which the Employee 
was receiving at the time of such termination, which payments shall be paid 
during the Severance Period in accordance with the Company's standard payroll 
practices; (ii) monthly severance payments during the Severance Period equal 
to 1/12th of the Employee's "target bonus" (as defined below) for the fiscal 
year in which the termination occurs (or for the prior fiscal year if a 
target bonus has not yet been determined for the fiscal year in which the 
termination occurs); (iii) continuation of all health and life insurance 
benefits through the end of the Severance Period substantially identical to 
those to which the Employee was entitled immediately prior to the 
termination, or to those being offered to officers of the Company, or a 
successor corporation, if the Company's benefit programs are changed during 
the Severance Period; (iv) full and immediate vesting of each unvested Option 
held by the Employee on the date of termination so that each such option 
shall be exercisable in full on the termination date in accordance with the 
provisions of the Option Agreement and Plan pursuant to which such option was 
granted; and (v) outplacement services with a total value not to exceed 
$15,000.  For purposes of this Agreement, the term "target bonus" shall mean 
the Employee's base salary in effect on the termination date multiplied by 
that percentage of such base salary that is prescribed by the Company under 
its Executive Bonus Program as the percentage of such base salary payable to 
the Employee as a bonus if the Company pays bonuses at one-hundred percent 
(100%) of its operating plan.

                    (iii) INVOLUNTARY TERMINATION FOR CAUSE.  If the 
Employee's employment is terminated for Cause, then the Employee shall not be 
entitled to receive severance payments.  The Employee's benefits will be 
terminated under the Company's then existing benefit plans and policies in 
accordance with such plans and policies in effect on the date of termination.

               (b)  TERMINATION APART FROM A CHANGE OF CONTROL.  In the event 
the Employee's employment terminates for any reason, either prior to the 
occurrence of a Change of Control or after the two year period following the 
effective date of a Change of Control, then the Employee shall not be 
entitled to receive any severance payments under this Agreement.  The 
Employee's benefits will be terminated under the terms of the Company's then 
existing benefit plans and policies in accordance with such plans and 
policies in effect on the date of termination or as otherwise determined by 
the Board of Directors of the Company.

                                       -3-
<PAGE>

          4.   DEFINITION OF TERMS.  The following terms referred to in this 
Agreement shall have the following meanings:

               (a)  CHANGE OF CONTROL.  "Change of Control" shall mean the 
occurrence of any of the following events:

                    (i)   OWNERSHIP.  Any "Person" (as such term is used in 
Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) 
is or becomes the "Beneficial Owner" (as defined in Rule 13d-3 under said 
Act), directly or indirectly, of securities of the Company representing 
twenty percent (20%) or more of the total voting power represented by the 
Company's then outstanding voting securities WITHOUT the approval of the 
Board of Directors of the Company; or

                    (ii)  MERGER/SALE OF ASSETS.  A merger or consolidation 
of the Company whether or not approved by the Board of Directors of the 
Company, other than a merger or consolidation which would result in the 
voting securities of the Company outstanding immediately prior thereto 
continuing to represent (either by remaining outstanding or by being 
converted into voting securities of the surviving entity) at least fifty 
percent (50%) of the total voting power represented by the voting securities 
of the Company or such surviving entity outstanding immediately after such 
merger or consolidation, or the stockholders of the Company approve a plan of 
complete liquidation of the Company or an agreement for the sale or 
disposition by the Company of all or substantially all of the Company's 
assets.

                    (iii) CHANGE IN BOARD COMPOSITION.  A change in the 
composition of the Board of Directors of the Company, as a result of which 
fewer than a majority of the directors are Incumbent Directors.  "Incumbent 
Directors" shall mean directors who either (A) are directors of the Company 
as of May 13, 1997 or (B) are elected, or nominated for election, to the 
Board of Directors of the Company with the affirmative votes of at least a 
majority of the Incumbent Directors at the time of such election or 
nomination (but shall not include an individual whose election or nomination 
is in connection with an actual or threatened proxy contest relating to the 
election of directors to the Company).

               (b)  CAUSE.  "Cause" shall mean (i) gross negligence or 
willful misconduct in the performance of the Employee's duties to the Company 
where such gross negligence or willful misconduct has resulted or is likely 
to result in substantial and material damage to the Company or its 
subsidiaries, (ii) repeated unexplained or unjustified absence from the 
Company, (iii) a material and willful violation of any federal or state law; 
(iv) commission of any act of fraud with respect to the Company; or (v) 
conviction of a felony or a crime involving moral turpitude causing material 
harm to the standing and reputation of the Company, in each case as 
determined in good faith by the Board of Directors of the Company.

               (c)  HOSTILE TAKEOVER.  "Hostile Takeover" shall mean a 
transaction or series of transactions that results in any Person becoming the 
Beneficial Owner, directly or indirectly, of securities of the Company 
representing more than 50% of the total voting power 

                                       -4-
<PAGE>

represented by the Company's then outstanding voting securities WITHOUT the 
approval of the Board of Directors of the Company.

               (d)  INVOLUNTARY TERMINATION.  "Involuntary Termination" shall 
include any termination by the Company other than for Cause and the 
Employee's voluntary termination, upon 30 days prior written notice to the 
Company, following (i) any reduction of the Employee's base compensation 
(other than in connection with a general decrease in base salaries for most 
similarly situated employees of the successor corporation); or (ii) the 
Employee's refusal to relocate to a location more than 50 miles from the 
Company's current location.

          5.   LIMITATION ON PAYMENTS.  To the extent that any of the 
payments or benefits provided for in this Agreement to the Employee 
constitute "parachute payments" within the meaning of Section 280G of the 
Internal Revenue Code of 1986, as amended (the "Code") and, but for this 
Section 5, would be subject to the excise tax imposed by Section 4999 of the 
Code, the Company shall reduce the aggregate amount of such payments and 
benefits such that the present value thereof (as determined under the Code 
and the applicable regulations) is equal to 2.99 times the Employee's "base 
amount" as defined in Section 280G(b)(3) of the Code.

          6.   CERTAIN BUSINESS COMBINATIONS.  In the event it is determined 
by the Board, upon consultation with Company management and the Company's 
independent auditors, that the enforcement of any Section of this Agreement, 
including, but not limited to, Section 2 hereof, which allows for the 
acceleration of vesting of option shares upon the effective date of a Change 
of Control, would preclude accounting for any proposed business combination 
of the Company involving a Change of Control as a pooling of interests, and 
the Board otherwise desires to approve such a proposed business transaction 
which requires as a condition to the closing of such transaction that it be 
accounted for as a pooling of interests, then any such Section of this 
Agreement shall be null and void.  For purposes of this Section 6, the 
Board's determination shall require the unanimous approval of the 
non-employee Board members.

          7.   SUCCESSORS.  Any successor to the Company (whether direct or 
indirect and whether by purchase, lease, merger, consolidation, liquidation 
or otherwise) to all or substantially all of the Company's business and/or 
assets shall assume the obligations under this Agreement and agree expressly 
to perform the obligations under this Agreement in the same manner and to the 
same extent as the Company would be required to perform such obligations in 
the absence of a succession.  The terms of this Agreement and all of the 
Employee's rights hereunder shall inure to the benefit of, and be enforceable 
by, the Employee's personal or legal representatives, executors, 
administrators, successors, heirs, distributees, devisees and legatees.

          8.   NOTICE.  Notices and all other communications contemplated by
this Agreement shall be in writing and shall be deemed to have been duly given
when personally delivered or when mailed by U.S. registered or certified mail,
return receipt requested and postage prepaid.  Mailed notices to the Employee
shall be addressed to the Employee at the 

                                       -5-
<PAGE>

home address which the Employee most recently communicated to the Company in 
writing.  In the case of the Company, mailed notices shall be addressed to 
its corporate headquarters, and all notices shall be directed to the 
attention of its Secretary.

          9.   MISCELLANEOUS PROVISIONS.

               (a)  NO DUTY TO MITIGATE.  The Employee shall not be required 
to mitigate the amount of any payment contemplated by this Agreement (whether 
by seeking new employment or in any other manner), nor, except as otherwise 
provided in this Agreement, shall any such payment be reduced by any earnings 
that the Employee may receive from any other source.

               (b)  WAIVER.  No provision of this Agreement shall be 
modified, waived or discharged unless the modification, waiver or discharge 
is agreed to in writing and signed by the Employee and by an authorized 
officer of the Company (other than the Employee).  No waiver by either party 
of any breach of, or of compliance with, any condition or provision of this 
Agreement by the other party shall be considered a waiver of any other 
condition or provision or of the same condition or provision at another time.

               (c)  WHOLE AGREEMENT.  No agreements, representations or 
understandings (whether oral or written and whether express or implied) which 
are not expressly set forth in this Agreement have been made or entered into 
by either party with respect to the subject matter hereof.  This Agreement 
supersedes any agreement of the same title and concerning similar subject 
matter dated prior to the date of this Agreement, and by execution of this 
Agreement both parties agree that any such predecessor agreement shall be 
deemed null and void.

               (d)  CHOICE OF LAW.  The validity, interpretation, 
construction and performance of this Agreement shall be governed by the laws 
of the State of California without reference to conflict of laws provisions.

               (e)  SEVERABILITY.  If any term or provision of this Agreement 
or the application thereof to any circumstance shall, in any jurisdiction and 
to any extent, be invalid or unenforceable, such term or provision shall be 
ineffective as to such jurisdiction to the extent of such invalidity or 
unenforceability without invalidating or rendering unenforceable the 
remaining terms and provisions of this Agreement or the application of such 
terms and provisions to circumstances other than those as to which it is held 
invalid or unenforceable, and a suitable and equitable term or provision 
shall be substituted therefor to carry out, insofar as may be valid and 
enforceable, the intent and purpose of the invalid or unenforceable term or 
provision.

               (f)  ARBITRATION.  Any dispute or controversy arising under or 
in connection with this Agreement may be settled at the option of either 
party by binding arbitration in the County of Santa Clara, California, in 
accordance with the rules of the American Arbitration Association then in 
effect. Judgment may be entered on the arbitrator's  award in any court 
having jurisdiction.  Punitive damages shall not be awarded.

                                       -6-
<PAGE>

               (g)  LEGAL FEES AND EXPENSES.  The parties shall each bear 
their own expenses, legal fees and other fees incurred in connection with 
this Agreement.

               (h)  NO ASSIGNMENT OF BENEFITS.  The rights of any person to 
payments or benefits under this Agreement shall not be made subject to option 
or assignment, either by voluntary or involuntary assignment or by operation 
of law, including (without limitation) bankruptcy, garnishment, attachment or 
other creditor's process, and any action in violation of this subsection (h) 
shall be void.

               (i)  EMPLOYMENT TAXES.  All payments made pursuant to this 
Agreement will be subject to withholding of applicable income and employment 
taxes.

               (j)  ASSIGNMENT BY COMPANY.  The Company may assign its rights 
under this Agreement to an affiliate, and an affiliate may assign its rights 
under this Agreement to another affiliate of the Company or to the Company; 
provided, however, that no assignment shall be made if the net worth of the 
assignee is less than the net worth of the Company at the time of assignment. 
In the case of any such assignment, the term "Company" when used in a section 
of this Agreement shall mean the corporation that actually employs the 
Employee.

               (k)  COUNTERPARTS.  This Agreement may be executed in 
counterparts, each of which shall be deemed an original, but all of which 
together will constitute one and the same instrument.

     IN WITNESS WHEREOF, each of the parties has executed this Agreement, in 
the case of the Company by its duly authorized officer, as of the day and 
year first above written.

CONCEPTUS, INC.                         EMPLOYEE

By:                                
   --------------------------------     --------------------------------     

Title:
      -----------------------------


                                       -7-

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             APR-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          13,594
<SECURITIES>                                    11,096
<RECEIVABLES>                                      412
<ALLOWANCES>                                        51
<INVENTORY>                                        151
<CURRENT-ASSETS>                                25,569
<PP&E>                                           1,741
<DEPRECIATION>                                     705
<TOTAL-ASSETS>                                  35,393
<CURRENT-LIABILITIES>                            1,681
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        63,452
<OTHER-SE>                                    (29,747)
<TOTAL-LIABILITY-AND-EQUITY>                    35,393
<SALES>                                            424
<TOTAL-REVENUES>                                   424
<CGS>                                              752
<TOTAL-COSTS>                                      752
<OTHER-EXPENSES>                                 2,894
<LOSS-PROVISION>                                     9
<INTEREST-EXPENSE>                                   3
<INCOME-PRETAX>                                (2,778)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,778)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,778)
<EPS-PRIMARY>                                   (0.30)
<EPS-DILUTED>                                   (0.30)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission